MX2017010883A - Composicion para el tratamiento de la infertilidad. - Google Patents
Composicion para el tratamiento de la infertilidad.Info
- Publication number
- MX2017010883A MX2017010883A MX2017010883A MX2017010883A MX2017010883A MX 2017010883 A MX2017010883 A MX 2017010883A MX 2017010883 A MX2017010883 A MX 2017010883A MX 2017010883 A MX2017010883 A MX 2017010883A MX 2017010883 A MX2017010883 A MX 2017010883A
- Authority
- MX
- Mexico
- Prior art keywords
- infertility
- treatment
- composition
- fsh
- preparations including
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Abstract
Preparaciones que incluyen FSH, por ejemplo, FSH recombinante, para el uso en el tratamiento de la infertilidad.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15164043 | 2015-04-17 | ||
PCT/EP2016/058358 WO2016166288A1 (en) | 2015-04-17 | 2016-04-15 | Composition for treatment of infertility |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017010883A true MX2017010883A (es) | 2017-12-07 |
Family
ID=52997893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017010883A MX2017010883A (es) | 2015-04-17 | 2016-04-15 | Composicion para el tratamiento de la infertilidad. |
Country Status (17)
Country | Link |
---|---|
US (3) | US10660938B2 (es) |
EP (2) | EP3662925B1 (es) |
JP (2) | JP7079094B2 (es) |
KR (1) | KR20170137041A (es) |
CN (1) | CN107405385A (es) |
AU (1) | AU2016247498B2 (es) |
CA (1) | CA2975444A1 (es) |
DK (2) | DK3283097T3 (es) |
ES (2) | ES2784625T3 (es) |
HU (2) | HUE048757T2 (es) |
MA (1) | MA46548B1 (es) |
MX (1) | MX2017010883A (es) |
PL (2) | PL3662925T3 (es) |
PT (2) | PT3283097T (es) |
RU (1) | RU2704252C2 (es) |
SI (2) | SI3283097T1 (es) |
WO (1) | WO2016166288A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018500934A (ja) * | 2014-12-22 | 2018-01-18 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Cmp依存性シアリダーゼ活性 |
AU2016247498B2 (en) | 2015-04-17 | 2021-06-03 | Ferring B.V. | Composition for treatment of infertility |
CN111050787A (zh) * | 2017-09-01 | 2020-04-21 | 辉凌公司 | 用于受控的卵巢刺激的组合物 |
JP2021522268A (ja) * | 2018-04-30 | 2021-08-30 | フェリング ベスローテン フェンノートシャップ | 制御された卵巣刺激のための組成物 |
TW202237173A (zh) * | 2020-12-09 | 2022-10-01 | 荷蘭商菲林公司 | 用於受控的卵巢刺激之組成物及方法 |
WO2023186331A1 (en) * | 2022-04-01 | 2023-10-05 | Ferring B.V. | Mixed protocol for treatment of infertility |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1228973B (de) * | 1961-05-13 | 1966-11-17 | Skf Kugellagerfabriken Gmbh | Streckwerk fuer Spinnereimaschinen |
US8173592B1 (en) * | 1999-03-31 | 2012-05-08 | Zentaris Ivf Gmbh | Method for a programmed controlled ovarian stimulation protocol |
TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
JO3092B1 (ar) * | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
AU2016247498B2 (en) | 2015-04-17 | 2021-06-03 | Ferring B.V. | Composition for treatment of infertility |
-
2016
- 2016-04-15 AU AU2016247498A patent/AU2016247498B2/en active Active
- 2016-04-15 PL PL20150379T patent/PL3662925T3/pl unknown
- 2016-04-15 PT PT167193150T patent/PT3283097T/pt unknown
- 2016-04-15 PL PL16719315T patent/PL3283097T3/pl unknown
- 2016-04-15 US US15/566,657 patent/US10660938B2/en active Active
- 2016-04-15 PT PT201503794T patent/PT3662925T/pt unknown
- 2016-04-15 HU HUE16719315A patent/HUE048757T2/hu unknown
- 2016-04-15 DK DK16719315.0T patent/DK3283097T3/da active
- 2016-04-15 RU RU2017128296A patent/RU2704252C2/ru active
- 2016-04-15 EP EP20150379.4A patent/EP3662925B1/en active Active
- 2016-04-15 MA MA46548A patent/MA46548B1/fr unknown
- 2016-04-15 SI SI201630710T patent/SI3283097T1/sl unknown
- 2016-04-15 MX MX2017010883A patent/MX2017010883A/es unknown
- 2016-04-15 EP EP16719315.0A patent/EP3283097B1/en active Active
- 2016-04-15 HU HUE20150379A patent/HUE054300T2/hu unknown
- 2016-04-15 KR KR1020177022439A patent/KR20170137041A/ko not_active Application Discontinuation
- 2016-04-15 CA CA2975444A patent/CA2975444A1/en active Pending
- 2016-04-15 WO PCT/EP2016/058358 patent/WO2016166288A1/en active Application Filing
- 2016-04-15 DK DK20150379.4T patent/DK3662925T3/da active
- 2016-04-15 SI SI201631184T patent/SI3662925T1/sl unknown
- 2016-04-15 ES ES16719315T patent/ES2784625T3/es active Active
- 2016-04-15 ES ES20150379T patent/ES2879838T3/es active Active
- 2016-04-15 CN CN201680015085.8A patent/CN107405385A/zh active Pending
- 2016-04-15 JP JP2017554361A patent/JP7079094B2/ja active Active
-
2020
- 2020-05-22 US US16/881,163 patent/US11439686B2/en active Active
- 2020-10-08 JP JP2020170254A patent/JP7161511B2/ja active Active
-
2022
- 2022-08-03 US US17/817,274 patent/US20230139407A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000710A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2019007021A (es) | Anticuerpos il-11ra. | |
MX2018005315A (es) | Composiciones y metodos para el tratamiento del cancer. | |
MY191581A (en) | Anti-pd-1 antibodies | |
MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
MX2020014120A (es) | Agonistas parciales del receptor de insulina. | |
CY1117214T1 (el) | Συνθεση για ελεγχομενη διεγερση των ωοθηκων | |
MX2017003478A (es) | Anticuerpos anti-fgfr2/3 y metodos para su uso. | |
SG10201803042PA (en) | Anti-tim-3 antibodies | |
GB2541571A (en) | Pharmaceutical compositions | |
MY192927A (en) | Fused bicyclic compounds for the treatment of disease | |
MX2017010883A (es) | Composicion para el tratamiento de la infertilidad. | |
MX369623B (es) | Compuestos biciclicos fusionados para el tratamiento de enfermedades. | |
MY191539A (en) | Streptococcal vaccine | |
MX2016009590A (es) | Composiciones de apilimod y métodos para usar las mismas. | |
MX2018000715A (es) | Metodos para tratar cancer usando apilimod. | |
MX2017008390A (es) | Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato. | |
MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
MX2018000395A (es) | Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso. | |
PH12017501864A1 (en) | Compositions and methods for treating autism | |
LT3380508T (lt) | Termostabilus fgf2 polipeptidas, jo panaudojimas | |
PH12017500602A1 (en) | Methods for treating ocular conditions | |
MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
MX370897B (es) | Compuestos bicíclicos fusionados para el tratamiento de enfermedades,. | |
MX2019003755A (es) | Regimen de dosificacion de avelumab para el tratamiento de cancer. |